Lucy Scientific Discovery Inc. (LSDIF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Aug 24, 2026
Lucy Scientific Discovery Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Cash & Equivalents | 0.21 | 1.67 | 0.05 | 0.25 | 0.05 |
Cash & Short-Term Investments | 0.21 | 1.67 | 0.05 | 0.25 | 0.05 |
Cash Growth | 710.16% | 3035.83% | -78.30% | 391.89% | - |
Accounts Receivable | 0 | 0.01 | - | - | - |
Other Receivables | 0.01 | 0.4 | 0.01 | 0.01 | 0.01 |
Receivables | 0.01 | 0.41 | 0.01 | 0.01 | 0.01 |
Prepaid Expenses | 1.12 | 1.22 | 0.19 | 0.07 | 0.04 |
Other Current Assets | - | 0.52 | 1.65 | 1.68 | - |
Total Current Assets | 1.34 | 3.82 | 1.9 | 2.01 | 0.1 |
Property, Plant & Equipment | - | 1.79 | 0.84 | 0.84 | - |
Other Intangible Assets | 1.45 | 1.48 | - | - | - |
Long-Term Deferred Charges | - | - | 1.87 | 2.68 | - |
Other Long-Term Assets | 1.5 | 1.68 | 0.02 | 0.02 | 0.02 |
Total Assets | 4.29 | 8.78 | 4.63 | 5.55 | 0.12 |
Liabilities
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Accounts Payable | 1.35 | 1.29 | 2.42 | 2.03 | 1.45 |
Accrued Expenses | 0.64 | 1.02 | 2.17 | 1.5 | 1.74 |
Current Portion of Long-Term Debt | - | 0.06 | 1.13 | 1.17 | 0.48 |
Current Portion of Leases | - | 0.34 | 0.09 | 0.08 | 0.06 |
Total Current Liabilities | 3.49 | 2.71 | 5.81 | 4.77 | 3.73 |
Long-Term Debt | - | - | 3.03 | 0.25 | 0.03 |
Long-Term Leases | - | 1.39 | 0.57 | 0.7 | 0.7 |
Other Long-Term Liabilities | 0.72 | - | - | 6.19 | - |
Total Liabilities | 4.21 | 4.1 | 9.41 | 11.91 | 4.46 |
Shareholders' Equity
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Common Stock | 49.03 | 48.93 | 30.79 | 23.57 | 20.29 |
Retained Earnings | -49.03 | -44.42 | -35.43 | -29.57 | -24.85 |
Comprehensive Income & Other | 0.08 | 0.16 | -0.14 | -0.35 | 0.22 |
Shareholders' Equity | 0.08 | 4.68 | -4.78 | -6.36 | -4.34 |
Total Liabilities & Equity | 4.29 | 8.78 | 4.63 | 5.55 | 0.12 |
Additional Metrics
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Total Debt | 0.07 | 1.79 | 4.82 | 2.19 | 1.27 |
Net Cash (Debt) | 0.14 | -0.11 | -4.77 | -1.95 | -1.22 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | 0.09 | -0.09 | -5.53 | -3.63 | -2.67 |
Filing Date Shares Outstanding | 1.76 | 1.76 | 1.04 | 6.48 | 4.68 |
Total Common Shares Outstanding | 1.76 | 1.75 | 1.04 | 6.48 | 4.68 |
Working Capital | -2.15 | 1.11 | -3.91 | -2.77 | -3.63 |
Book Value Per Share | 0.05 | 2.68 | -4.58 | -0.98 | -0.93 |
Tangible Book Value | -1.36 | 3.19 | -4.78 | -6.36 | -4.34 |
Tangible Book Value Per Share | -0.77 | 1.83 | -4.58 | -0.98 | -0.93 |